CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]SHOW COLUMNS FROM wpe5_wpsecure_login LIKE "country"
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD country VARCHAR(150)
WordPress database error: [Table 'acdlpb3_wp339.wpe5_wpsecure_login' doesn't exist]ALTER TABLE wpe5_wpsecure_login ADD city VARCHAR(100)
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Data continue to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19.
Data from two CDC reports today show COVID-19 vaccine boosters remain safe and continue to be highly effective against severe disease over time.
The United States is fortunate to have highly effective vaccines that are widely available for those aged 12 and up. People who are fully vaccinated are protected from severe disease and death, including from the variants currently circulating in the country such as Delta.